|
Status |
Public on Nov 26, 2020 |
Title |
SH-SY5Y WT+FCCP_2 |
Sample type |
protein |
|
|
Source name |
SH-SY5Y WT
|
Organism |
Homo sapiens |
Characteristics |
cell line: SH-SY5Y treatment: FCCP mutation in sacs: WT
|
Treatment protocol |
Cell lines were treated with CRISPR/Cas9 gene editing to produce clones harboring a loss-of function mutation in SACS; both cell lines and primary fibroblasts were treated with 20 μM carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) for 2 hours to induce mitochondrial damage and fragmentation.
|
Growth protocol |
Cells were grown at 37 °C with 5% CO2 in Dulbecco’s modified Eagle’s medium, containing 10% FBS, 4.5 g/L glucose and 1% antibiotics/antimycotics; primary cells from humans were grown at 37 °C with 5% CO2 in Dulbecco’s modified Eagle’s medium, containing 10% FBS, 4.5 g/L glucose and 1% antibiotics/antimycotics.
|
Extracted molecule |
protein |
Extraction protocol |
All samples (fibroblasts and cell models) were washed twice with PBS 1X and then homogenized in M-PER™ Mammalian Protein Extraction Reagent (Thermo Scientific, Rodano (MI), Italy) containing inhibitors of proteases (Roche Diagnostics, Monza (MB), Italy), following the manufacturer’s standard protocol.
|
Label |
Cy3
|
Label protocol |
Labeling was performed at Somalogic
|
|
|
Hybridization protocol |
Hybridization was performed at Somalogic
|
Scan protocol |
Agilent scanner for microarrays
|
Data processing |
Sample data is rst normalized to remove hybridization variation within a run followed by median normalization across all samples to remove other assay biases within the run and finally calibrated to remove assay differences between runs.
|
|
|
Submission date |
Nov 25, 2020 |
Last update date |
Nov 26, 2020 |
Contact name |
giovanna chiorino |
E-mail(s) |
giovanna.chiorino@gmail.com
|
Organization name |
Fondo Edo Tempia
|
Department |
Cancer Genomics
|
Street address |
via malta 3
|
City |
Biella |
ZIP/Postal code |
13900 |
Country |
Italy |
|
|
Platform ID |
GPL23119 |
Series (1) |
GSE162132 |
Functional Network Profiles In Arsacs Disclosed By Aptamer-Based Proteomic Technology |
|